CAR T Cells — A New Horizon for Autoimmunity?

The management of autoimmune diseases has improved substantially since the turn of the century, owing largely to the emergence of targeted biologic therapies. Nonetheless, treatment is still considered to be disease-suppressive and lifelong in most cases. In this issue of the Journal , Müller et al....

Ausführliche Beschreibung